Estrone: The Complex Role of a Key Estrogen Metabolite in Women’s Health

Estrone, designated as E1 in biochemical nomenclature, represents one of the three primary estrogens produced in the female body, yet its physiological significance is frequently misunderstood by conventional medicine. Unlike estradiol, which is the dominant estrogen during reproductive years, estrone is the only form of estrogen naturally present in any quantity in post-menopausal women, earning it the descriptive nickname “old lady estrogen.” [A-5] This distinction is critical for understanding the hormonal transitions women experience throughout their lifespan, particularly as ovarian function declines during perimenopause and menopause.

The molecular structure of estrone, like that of progesterone and testosterone, makes it susceptible to degradation when exposed to various biological and environmental conditions. As documented in groundbreaking research published in 1993 in the journal Radiation Physics and Chemistry, estrone, progesterone, and testosterone lose electrons when exposed to UV light, pH changes, and temperature fluctuations, becoming toxic and often carcinogenic metabolites known as “hormone transients.” [A-1][A-2] Austrian researchers investigating whether these hormone transients could be regenerated discovered that vitamin C, a potent electron donor, was capable of an astonishing 90.9% regeneration of estrone—nearly complete restoration of the hormone’s functional structure. [A-1][A-2] This finding has profound implications for cancer prevention and hormone health, as the regeneration of hormones through electron transfer processes may offer a new pathway for reducing the formation of cancer-initiating metabolites. [A-1]

Estrone is secreted by both the ovaries and the adrenal cortex, and its relationship with estradiol is governed by an ideal ratio of approximately 1 to 2. [A-5] However, as women age, this balance can become disturbed, leading to a condition strongly associated with breast cancer development. Notably, in premenopausal women, testosterone can also be converted into excessive estrone—a situation that can be addressed through supplementation with diindolylmethane (DIM), a compound derived from cruciferous vegetables. [A-5][A-7] DIM promotes beneficial estrogen metabolism by increasing the production of 2-hydroxy estrogen by 75% while decreasing the production of 16-hydroxy estrone, which is considered the “bad” form of estrogen with carcinogenic potential. [A-7] This modulation of estrogen metabolism is critical because improper estrogen metabolism can lead to oxidation, DNA damage, and cancer promotion. [A-7]

The three main estrogens—estradiol, estrone, and estriol—differ substantially in potency and receptor activity. Estradiol is 12 times more potent than estrone and 80 times more potent than estriol. [A-4] Furthermore, estrone predominantly acts through the estrogen receptor-alpha, which promotes breast cell proliferation, whereas estriol primarily acts through the beta receptor, which inhibits proliferation. [A-4] This receptor selectivity explains why doctors who prescribe bio-identical estrogen therapy typically combine estriol with estradiol in an 80:20 ratio, as estriol appears to act as a modulator of the more potent estradiol and is protective against breast cancer. [A-4]

Remarkably, nature provides plant-based alternatives that can support estrone balance without the carcinogenic risks associated with synthetic hormone therapies. Pomegranate, whose anatomical resemblance to human ovaries is striking, contains an estrogen structurally and functionally similar to estrone found in mammals. [A-6] Studies indicate that at 17 mg per kilogram, pomegranate is one of the highest known plant sources for estrone. [A-6] In a 2004 study published in the Journal of Ethnopharmacology, female rats whose ovaries were removed developed accelerated bone loss, uterine weight loss, and depressive symptoms—effects that were reversed when administered pomegranate extract. [A-6] Despite its powerful estrogenic properties, pomegranate does not exhibit the carcinogenic potential associated with synthetic or horse-derived estrogens; rather, it has been shown to selectively modulate estrogen receptors in ways beneficial to the organism while down-regulating activity at receptors associated with estrogen-sensitive cancers. [A-6]

For women seeking to understand their hormonal health, bio-identical hormone replacement therapy offers a safer alternative to conventional approaches. Bio-identical hormones such as estradiol, estriol, and estrone are molecularly identical replicas of the hormones naturally produced by the human body, unlike the synthetic conjugated compounds derived from pregnant mare urine used in products like Premarin. [A-3][A-5] The Women’s Health Initiative study, which revealed increased risks of breast cancer, heart disease, and stroke with conventional HRT, specifically evaluated synthetic progestins rather than natural progesterone. [A-3][A-4] Subsequent research has demonstrated that combining estrogen with natural, unadulterated progesterone does not increase the risk of breast cancer, whereas synthetic progestins are potentially harmful. [A-4]